(Total Views: 216)
Posted On: 07/28/2022 4:46:48 PM
Post# of 1418
Not hard to do the math on the number of long covid sufferers x and estimate of Todos's share
What is it? Estimated 23 million in the US? 100 million worldwide?
I estimate the test would be $500-$1000
For fun, let's use all low numbers. The test is sold to 1% that pay the lowest $500 which Todos gets 1/2. That's $57M clams.
Heck, even if it was a 1/10th of a percent, that would be $5M clams.
btw, the $500 number is low.
Great to invest in a stock that actually makes money, growing revenue and has unlimited potential in the short-term.
Oh and actually informs shareholders what is going on
Todos Medical Partners with Amerimmune Diagnostics on Long COVID Biomarker Panel - July 28, 2022 7:30am EDT
https://investor.todosmedical.com/news-events...cs-on-long
What is it? Estimated 23 million in the US? 100 million worldwide?
I estimate the test would be $500-$1000
For fun, let's use all low numbers. The test is sold to 1% that pay the lowest $500 which Todos gets 1/2. That's $57M clams.
Heck, even if it was a 1/10th of a percent, that would be $5M clams.
btw, the $500 number is low.
Great to invest in a stock that actually makes money, growing revenue and has unlimited potential in the short-term.
Oh and actually informs shareholders what is going on
Todos Medical Partners with Amerimmune Diagnostics on Long COVID Biomarker Panel - July 28, 2022 7:30am EDT
https://investor.todosmedical.com/news-events...cs-on-long
(1)
(0)Scroll down for more posts ▼
